Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3Gastrointestinal 3Gynecologic 1Dermatologic 1

Conditions

Melanoma 147Carcinoma, Non-Small-Cell Lung 34Skin Neoplasms 28Colorectal Neoplasms 28Breast Neoplasms 25Lung Neoplasms 24Carcinoma, Renal Cell 21Ovarian Neoplasms 20Neoplasms 20Squamous Cell Carcinoma of Head and Neck 19Carcinoma, Basal Cell 19Carcinoma, Merkel Cell 18Sarcoma 17Prostatic Neoplasms 17Pancreatic Neoplasms 16Neoplasm Metastasis 15Head and Neck Neoplasms 14Stomach Neoplasms 13Thyroid Neoplasms 12Uterine Cervical Neoplasms 11Urinary Bladder Neoplasms 11Carcinoma, Hepatocellular 11Lymphoma, T-Cell, Cutaneous 10Esophageal Neoplasms 10Carcinoma, Transitional Cell 9Uveal Melanoma 8Triple Negative Breast Neoplasms 8Mycosis Fungoides 8Colonic Neoplasms 8Small Cell Lung Carcinoma 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Pancreatic Ductal × Dermatologic × 30 days × Clear all
NCT05379985 2026-05-15

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Revolution Medicines, Inc.

Phase 1/2 Recruiting
754 enrolled
DermatologicGastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Gastrointestinal Neoplasms, Intestinal Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Neoplastic Processes, Pancreatic Neoplasms, Thoracic Neoplasms, Colorectal Neoplasms, Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡